Lost in translation: A disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion

Authors

Grazia Aleppo, Northwestern University
Christopher G Parkin, CGParkin Communications, Inc.
Anders L Carlson, University of Minnesota Medical School
Rodolfo J Galindo, Emory University
Davida F Kruger, Henry Ford Health System
Carol J Levy, Mount Sinai School of Medicine
Guillermo E Umpierrez, Emory University
Gregory P Forlenza, University of Colorado Denver
Janet B McGill, Washington University School of Medicine in St. Louis

Journal

Diabetes technology & therapeutics

Publication Date

10-1-2021

Volume

23

Issue

10

First Page

715

Last Page

725

Document Type

Open Access Publication

DOI

10.1089/dia.2021.0196

Rights and Permissions

Aleppo, G., Parkin, C. G., Carlson, A. L., et al. (2021) Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. Diabetes Technology & Therapeutics, 23(10), 715-725. https://doi.org/10.1089/dia.2021.0196 This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is a copy of an article published in the Diabetes technology & therapeutics © 2021 © Mary Ann Liebert, Inc.; Diabetes technology & therapeutics is available online at: http://online.liebertpub.com.

Recommended Citation

Aleppo, Grazia; Parkin, Christopher G; Carlson, Anders L; Galindo, Rodolfo J; Kruger, Davida F; Levy, Carol J; Umpierrez, Guillermo E; Forlenza, Gregory P; and McGill, Janet B, "Lost in translation: A disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion." Diabetes technology & therapeutics. 23, 10. 715 - 725. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11101